A subset of virus-specific CD161 T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

Citation data:

Blood, ISSN: 1528-0020, Vol: 129, Issue: 6, Page: 740-758

Publication Year:
2017
Usage 5
Abstract Views 5
Captures 9
Readers 9
Social Media 11
Tweets 11
Citations 3
Citation Indexes 3
PMID:
27821506
DOI:
10.1182/blood-2016-05-713347
Author(s):
Alsuliman, Abdullah, Muftuoglu, Muharrem, Khoder, Ahmad, Ahn, Yong-Oon, Basar, Rafet, Verneris, Michael R, Muranski, Pawel, Barrett, A John, Liu, Enli, Li, Li, Stringaris, Kate, Armstrong-James, Darius, Shaim, Hila, Kondo, Kayo, Imahashi, Nobuhiko, Andersson, Borje, Marin, David, Champlin, Richard E, Shpall, Elizabeth J, Rezvani, Katayoun Show More Hide
Publisher(s):
American Society of Hematology
Tags:
Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, Medicine
Most Recent Tweet View All Tweets
article description
The establishment of long-lived pathogen-specific T cells is a fundamental property of the adaptive immune response. However, the mechanisms underlying long-term persistence of antigen-specific CD4 T cells are not well-defined. Here we identify a subset of memory CD4 T cells capable of effluxing cellular toxins, including rhodamine (Rho), through the multidrug efflux protein MDR1 (also known as P-glycoprotein and ABCB1). Drug-effluxing CD4 T cells were characterized as CD161CD95CD45RACD127CD28CD25 cells with a distinct chemokine profile and a Th1-polarized pro-inflammatory phenotype. CD4CD161Rho-effluxing T cells proliferated vigorously in response to stimulation with anti-CD3/CD28 beads and gave rise to CD161 progeny in vitro. These cells were also capable of self-renewal and maintained their phenotypic and functional characteristics when cultured with homeostatic cytokines. Multidrug-effluxing CD4CD161 T cells were enriched within the viral-specific Th1 repertoire of healthy donors and patients with acute myeloid leukemia (AML) and survived exposure to daunorubicin chemotherapy in vitro. Multidrug-effluxing CD4CD161 T cells also resisted chemotherapy-induced cytotoxicity in vivo and underwent significant expansion in AML patients rendered lymphopenic after chemotherapy, contributing to the repopulation of anti-CMV immunity. Finally, after influenza vaccination, the proportion of influenza-specific CD4 T cells coexpressing CD161 was significantly higher after 2 years compared with 4 weeks after immunization, suggesting CD161 is a marker for long-lived antigen-specific memory T cells. These findings suggest that CD4CD161 T cells with rapid efflux capacity contribute to the maintenance of viral-specific memory T cells. These data provide novel insights into mechanisms that preserve antiviral immunity in patients undergoing chemotherapy and have implications for the development of novel immunotherapeutic approaches.

This article has 0 Wikipedia mention.